Status:
COMPLETED
Trans GERD: Efficacy and Tolerability of Esomeprazol in Patients Under Ordinary Medical Care Conditions
Lead Sponsor:
AstraZeneca
Conditions:
Gastrointestinal Diseases
Eligibility:
All Genders
Brief Summary
Under daily routine conditions and without any intervention by the sponsor regarding the selection of subjects, diagnostic procedures, therapeutic decisions (medicinal and non- medicinal therapy, dose...
Eligibility Criteria
Inclusion
- patients with gastrointestinal disorders and patients with acid associated gastrointestinal symptoms treated with esomeprazole.
Exclusion
- limitiations; possible risks; warnings; contraindications mentioned in the SPC.
Key Trial Info
Start Date :
January 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
29586 Patients enrolled
Trial Details
Trial ID
NCT00612027
Start Date
January 1 2006
Last Update
February 11 2008
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.